BEIJING, April 4, 2025 /PRNewswire/ -- Recently, Beijing Tsingke Biotech Co., Ltd. officially announced the appointment of Dr. Yaning Wang, a former senior expert at the FDA, as the company's Chief Scientific Advisor in the field of small nucleic acid. This collaboration injects strong momentum into Tsingke's growth in small nucleic acid drugs raw materials, marking a significant enhancement in the company's technical capabilities, regulatory compliance, and quality control.
Dr. Yaning Wang's Industry Experience and Contributions
As the global small nucleic acid drugs market rapidly expands, driven by growing demand for precise treatments targeting genetic disorders, rare diseases, and cancer. The high specificity of small nucleic acid drugs makes them particularly promising for rare diseases caused by single-gene mutations. However, this progress also comes with technical hurdles and increasingly stringent regulatory requirements. Amidst the surging market and growing regulatory challenges, Dr. Yaning Wang joins Tsingke at this pivotal moment to strengthen our capabilities on RNA technologies. His expertise will help Tsingke drive the development of high-quality, customized small nucleic acid solutions while accelerating innovation in nucleic acid drug development.
Dr. Yaning Wang has extensive experience and outstanding achievements in the pharmaceutical industry. He obtained his Bachelor's degree in Pharmacy from Peking University in 1996, followed by a Master's degree in Biochemistry from the National Anti-Doping Center in 1999. In 2003, he earned a dual degree-a Ph.D. in Pharmacy and a Master's in Statistics-from the University of Florida.
During his tenure at the U.S. Food and Drug Administration (FDA), Dr. Wang held several key positions, ultimately serving as Director of the Division of Quantitative Pharmacology in the Office of Clinical Pharmacology. He played a leading role in the approval of multiple new drugs, ensuring their safety and efficacy, and made significant contributions to the advancement of global drug regulation.
"We are thrilled to welcome Dr. Yaning Wang to Tsingke. His extensive expertise and remarkable contributions to the pharmaceutical industry will undoubtedly strengthen Tsingke position in the rapidly evolving field of small nucleic acids. Through its collaboration with Dr. Wang, Tsingke will integrate the latest global regulatory standards and compliance guidelines, strengthening regulatory management capabilities to ensure its products meet the highest quality and safety standards in complex market environments," said Shijin Ma, President of Tsingke.
About Tsingke
Tsingke leads DNA/RNA synthesis with a full-chain platform offering gene synthesis, oligo modification, antibodies, proteins, gene regulation, and detection. Backed by a 12,000㎡ R&D facility, a 100,000-class clean workshop, and 300+ IP rights, Tsingke delivers high-quality solutions trusted by 300,000+ customers worldwide.
In small nucleic acid drug development, Tsingke drives innovation in synthesis, modification, delivery, and scale-up. With an end-to-end service model-from sequence design to validation-the company supports both research and GMP-grade production through its large-scale oligo API platform. By ensuring drug safety and delivery efficiency, Tsingke provides global researchers with tailored solutions and expert support.
For more information on Tsingke, please visit https://www.tsingke.com/ or connect with us on LinkedIn at https://www.linkedin.com/company/tsingke/.
Beijing Tsingke Biotech Co., Ltd.
market@tsingke.com.cn
https://www.tsingke.com/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Ex-FDA Expert Dr. Yaning Wang Joins Tsingke to Drive Small Nucleic Acid Drug Innovation
|
VICTORIA, Seychelles, April 7, 2026 /PRNewswire/ -- MEXC, the world leader in 0‑fee digital asset trading, has listed two Ondo tokenized stock trading pairs on its spot market, tied to leading quantum computing companies. The move further expands the range of real-world assets (RWA) available to users on the platform.
IONQON/USDT and RGTION/USDT were listed on April 6, 2026, at 12:00 UTC. Withdrawals are enabled from April 7, 2026, at 12:00 UTC.
IONQON and RGTION represent tokenized versions of IonQ and Rigetti Computing, two publicly listed pure-play quantum computing companies at the forefront of a sector gaining increasing commercial momentum. Both tokens are issued through Ondo Global Markets, a platform designed to bring traditional public securities onchain, with tokens that are freely transferable and usable in DeFi.
The listings reflect MEXC's broader commitment to serving as a bridge between traditional financial markets and the digital asset ecosystem. By integrating tokenized real-world assets into its platform, MEXC enables users to access infinite opportunities across diverse markets within a single interface. Guided by a user-centered approach, MEXC continues to enhance its platform, ensuring users have timely and efficient access to relevant trading solutions as markets evolve.
About MEXC
Founded in 2018, MEXC is committed to being "Your Easiest Way to Crypto." Serving over 40 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.
MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC
Risk Disclaimer:
This content does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, project fundamentals, and potential financial risks before making any trading decisions.
VICTORIA, Seychelles, April 7, 2026 /PRNewswire/ -- MEXC, the world leader in 0‑fee digital asset trading, has listed two Ondo tokenized stock trading pairs on its spot market, tied to leading quantum computing companies. The move further expands the range of real-world assets (RWA) available to users on the platform.
IONQON/USDT and RGTION/USDT were listed on April 6, 2026, at 12:00 UTC. Withdrawals are enabled from April 7, 2026, at 12:00 UTC.
IONQON and RGTION represent tokenized versions of IonQ and Rigetti Computing, two publicly listed pure-play quantum computing companies at the forefront of a sector gaining increasing commercial momentum. Both tokens are issued through Ondo Global Markets, a platform designed to bring traditional public securities onchain, with tokens that are freely transferable and usable in DeFi.
The listings reflect MEXC's broader commitment to serving as a bridge between traditional financial markets and the digital asset ecosystem. By integrating tokenized real-world assets into its platform, MEXC enables users to access infinite opportunities across diverse markets within a single interface. Guided by a user-centered approach, MEXC continues to enhance its platform, ensuring users have timely and efficient access to relevant trading solutions as markets evolve.
About MEXC
Founded in 2018, MEXC is committed to being "Your Easiest Way to Crypto." Serving over 40 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.
MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC
Risk Disclaimer:
This content does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, project fundamentals, and potential financial risks before making any trading decisions.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
MEXC Lists Two Ondo Tokenized Stock Trading Pairs Tied to Quantum Computing Sector
